<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7102632/results/search/test_trace/results.xml">
  <result pre="determine its relationship to animal viruses, and evaluate factors conferring" exact="infection" post="susceptibility and resistance. These foundational results are being advanced"/>
  <result pre="bats that are known to have the potential for human" exact="infection" post="[2]. Thus, 2019-nCoV is now renamed ‘SARS-CoV-2’. It is"/>
  <result pre="over 80 000 individuals as of 25 February 2020. The" exact="infection" post="is associated with a SARS-like disease [3], with a"/>
  <result pre="these methods, they verified the respiratory tract as a principal" exact="infection" post="site and established preliminary time courses of virus amplification"/>
  <result pre="define transmissibility periods and inform public health authorities on appropriate" exact="quarantine" post="measures. In addition, the Shi group isolated SARS-CoV-2 from"/>
  <result pre="infected primary human airway epithelial cells [3]. Using in vitro" exact="infection" post="assays, Zhou et al. discovered that convalescent sera from"/>
  <result pre="target cell membrane. Features of SARS-CoV-2 that may facilitate human" exact="infection" post="include: (1) S1B receptor-binding motifs (RBMs) (in green) that"/>
  <result pre="to host protease cleavages [9]. Antiviral antibodies (lower-left inset) prevent" exact="infection" post="by: (a) binding S1B RBMs, blocking receptor access; (b)"/>
  <result pre="using cell culture models will further address this question, when" exact="testing" post="human cell infection with SARS-related animal CoVs and paying"/>
  <result pre="models will further address this question, when testing human cell" exact="infection" post="with SARS-related animal CoVs and paying close attention to"/>
 </snippets>
</snippetsTree>
